John D. McMannis

3.0k total citations
57 papers, 1.4k citations indexed

About

John D. McMannis is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, John D. McMannis has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 25 papers in Immunology and 16 papers in Genetics. Recurrent topics in John D. McMannis's work include Hematopoietic Stem Cell Transplantation (28 papers), Immunotherapy and Immune Responses (14 papers) and Immune Cell Function and Interaction (12 papers). John D. McMannis is often cited by papers focused on Hematopoietic Stem Cell Transplantation (28 papers), Immunotherapy and Immune Responses (14 papers) and Immune Cell Function and Interaction (12 papers). John D. McMannis collaborates with scholars based in United States, United Kingdom and Italy. John D. McMannis's co-authors include Richard E. Champlin, Sergio Giralt, Marcos de Lima, Krishna V. Komanduri, Lisa S. St. John, Jeffrey J. Molldrem, Chitra Hosing, Elizabeth J. Shpall, Eric Wieder and Rima M. Saliba and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

John D. McMannis

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. McMannis United States 18 900 605 420 270 247 57 1.4k
Ruth Seggewiss Germany 16 722 0.8× 567 0.9× 374 0.9× 384 1.4× 322 1.3× 26 1.4k
Uta Oelschlägel Germany 22 1.2k 1.3× 635 1.0× 488 1.2× 392 1.5× 428 1.7× 53 1.8k
Mary Laughlin United States 12 1.1k 1.2× 390 0.6× 360 0.9× 575 2.1× 232 0.9× 28 1.5k
Steve Kornblau United States 10 1.2k 1.3× 404 0.7× 369 0.9× 253 0.9× 222 0.9× 16 1.4k
Raynier Devillier France 23 1.1k 1.2× 478 0.8× 432 1.0× 278 1.0× 314 1.3× 84 1.5k
Takahiro Shima Japan 14 650 0.7× 643 1.1× 491 1.2× 271 1.0× 541 2.2× 59 1.5k
Stelvio Ballanti Italy 13 1.5k 1.7× 885 1.5× 584 1.4× 163 0.6× 307 1.2× 28 1.8k
Jacopo Mariotti Italy 20 562 0.6× 667 1.1× 410 1.0× 110 0.4× 158 0.6× 56 1.2k
Jérôme Rey France 22 596 0.7× 605 1.0× 347 0.8× 527 2.0× 307 1.2× 76 1.4k
Tatsuya Fujioka Japan 19 750 0.8× 451 0.7× 277 0.7× 161 0.6× 448 1.8× 60 1.3k

Countries citing papers authored by John D. McMannis

Since Specialization
Citations

This map shows the geographic impact of John D. McMannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. McMannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. McMannis more than expected).

Fields of papers citing papers by John D. McMannis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. McMannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. McMannis. The network helps show where John D. McMannis may publish in the future.

Co-authorship network of co-authors of John D. McMannis

This figure shows the co-authorship network connecting the top 25 collaborators of John D. McMannis. A scholar is included among the top collaborators of John D. McMannis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. McMannis. John D. McMannis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Charles, David J. Stewart, J. Jack Lee, et al.. (2012). Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans. PLoS ONE. 7(4). e34833–e34833. 144 indexed citations
2.
Schuster, Stephen J., Chitra Hosing, Elizabeth J. Shpall, et al.. (2011). Adoptive Immunotherapy with Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy in Patients with Chronic Lymphocytic Leukemia. Blood. 118(21). 2855–2855. 1 indexed citations
3.
Spellman, Stephen R., Carolyn Katovich Hurley, Colleen A. Brady, et al.. (2011). Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood. Cytotherapy. 13(7). 848–855. 23 indexed citations
4.
McKenna, David H., Darin Sumstad, John D. McMannis, et al.. (2011). Interlaboratory assessment of a novel colony‐forming unit assay: a multicenter study by the cellular team of Biomedical Excellence for Safer Transfusion (BEST) collaborative. Transfusion. 51(9). 2001–2005. 6 indexed citations
5.
Ciurea, Stefan O., Victor E. Mulanovich, Ying Jiang, et al.. (2010). Lymphocyte Recovery Predicts Outcomes in Cord Blood and T Cell–Depleted Haploidentical Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(8). 1169–1175. 31 indexed citations
6.
Laughlin, Mary, Joanne Kurtzberg, John D. McMannis, & Lawrence D. Petz. (2010). Eighth Annual International Umbilical Cord Blood Transplantation Symposium, San Francisco, California, June 3-5, 2010. Biology of Blood and Marrow Transplantation. 17(2). 176–189. 1 indexed citations
7.
Hosing, Chitra, Rima M. Saliba, Martin Körbling, et al.. (2009). Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. American Journal of Hematology. 84(6). 335–337. 82 indexed citations
8.
Cheng, Yee Chung, Gabriela Rondón, John D. McMannis, et al.. (2009). Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. International Journal of Hematology. 90(5). 627–634. 3 indexed citations
9.
Rondón, Gabriela, Rima M. Saliba, Issa F. Khouri, et al.. (2008). Long-Term Follow-Up of Patients Who Experienced Graft Failure Postallogeneic Progenitor Cell Transplantation. Results of a Single Institution Analysis. Biology of Blood and Marrow Transplantation. 14(8). 859–866. 57 indexed citations
10.
11.
Lu, Charles, Lin Ji, Rajagopal Ramesh, et al.. (2007). Systemic therapy with tumor suppressor FUS1-nanoparticles for stage IV lung cancer. Cancer Research. 67. 7 indexed citations
12.
Xing, Dongxia, Wendy Fang, William K. Decker, et al.. (2007). Ex Vivo Expansion of Cord Blood NK Cell Have In Vivo Efficacy Against Leukemia.. Blood. 110(11). 2741–2741. 2 indexed citations
13.
Hosing, Chitra, Muzaffar H. Qazilbash, Partow Kebriaei, et al.. (2006). Fixed‐dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. British Journal of Haematology. 133(5). 533–537. 38 indexed citations
14.
Lemarié, Claude, et al.. (2006). Purification of monocytes from cryopreserved mobilized apheresis products by elutriation with the Elutra® device. Journal of Immunological Methods. 318(1-2). 30–36. 12 indexed citations
15.
Hosing, Chitra, Rima M. Saliba, Martin Körbling, et al.. (2006). High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma. Leukemia & lymphoma. 47(7). 1290–1294. 8 indexed citations
16.
17.
Khouri, Issa F., Ming-Sheng Lee, Rima M. Saliba, et al.. (2004). Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival. Experimental Hematology. 32(1). 28–35. 92 indexed citations
18.
Lima, Marcos de, Lisa S. St. John, Eric Wieder, et al.. (2002). Double‐chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. British Journal of Haematology. 119(3). 773–776. 59 indexed citations
19.
Claxton, David F., John D. McMannis, Marcos de Lima, Richard E. Champlin, & Aniruddha Choudhury. (2000). Generation and clinical useofleuimiaderived dendritic cell activated lymphocytes in patients with chronic myelogenous leukemia (CML). Blood. 96. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Seggewiss Breakdown of academic impact, for papers by Uta Oelschlägel Breakdown of academic impact, for papers by Mary Laughlin Breakdown of academic impact, for papers by Steve Kornblau Breakdown of academic impact, for papers by Raynier Devillier Breakdown of academic impact, for papers by Takahiro Shima Breakdown of academic impact, for papers by Stelvio Ballanti Breakdown of academic impact, for papers by Jacopo Mariotti Breakdown of academic impact, for papers by Jérôme Rey Breakdown of academic impact, for papers by Tatsuya Fujioka
Rankless by CCL
2026